Michael V.G. Latronico

Humanitas University — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

34h-index8.6kcitations72works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(18), Circular RNAs in diseases(13), Cancer-related molecular mechanisms research(8), Pancreatic function and diabetes(8), Diabetes and associated disorders(7)

Publications71 total

Corrigendum: 3D hydrogel environment rejuvenates aged pericytes for skeletal muscle tissue engineering
Frontiers in Physiology·2019· 1 citedOpen Access
<i>Salmonella</i> serotypes isolated in geckos kept in seven collections in southern Italy
Journal of Small Animal Practice·2018· 7 cited
Chemerin processing in the myocardium: A mechanism in search of a function
Journal of Molecular and Cellular Cardiology·2016· 1 cited
DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy
Nature Communications·2016· 162 citedOpen Access
It’s Time for An Epigenomics Roadmap of Heart Failure
Current Genomics·2015· 11 citedOpen Access
Therapeutic applications of noncoding RNAs
Current Opinion in Cardiology·2015· 21 cited
FABP3 as Biomarker of Heart Pathology
Biomarkers in disease·2015· 6 cited
DOT1L-mediated H3K79me2 modification critically regulates gene expression during cardiomyocyte differentiation
Cell Death and Differentiation·2014· 81 citedOpen Access
3D hydrogel environment rejuvenates aged pericytes for skeletal muscle tissue engineering
Frontiers in Physiology·2014· 110 citedOpen Access
Reply
JACC: Cardiovascular Interventions·2014· 2 cited
microRNAs in Cardiovascular Diseases
Journal of the American College of Cardiology·2014· 363 cited
PlGF–MMP9-engineered iPS cells supported on a PEG–fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium
Cell Death and Disease·2014· 63 citedOpen Access
FABP3 as Biomarker of Heart Pathology
2014
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy
Proceedings of the National Academy of Sciences·2013· 232 citedOpen Access
Routine Assessment of On-Clopidogrel Platelet Reactivity and Gene Polymorphisms in Predicting Clinical Outcome Following Drug-Eluting Stent Implantation in Patients With Stable Coronary Artery Disease
JACC: Cardiovascular Interventions·2013· 54 cited
MicroRNA-Dependent Control of the Cardiac Fibroblast Secretome
Circulation Research·2013· 3 citedOpen Access
Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology·2013· 318 citedOpen Access
Long Noncoding RNA: a New Player of Heart Failure?
Journal of Cardiovascular Translational Research·2013· 103 citedOpen Access
Epigenetics: a new mechanism of regulation of heart failure?
Basic Research in Cardiology·2013· 73 citedOpen Access
A collagen membrane-based engineered heart tissue improves cardiac function in ischemic rat hearts
Bioinspired Biomimetic and Nanobiomaterials·2012
page 1 of 4Next →

Frequent Co-authors

Gianluigi Condorelli(39), Daniele Catalucci(10), Gianpaolo Papaccio(8), Roberto Papait(7), F. Pisanti(7), Roberto Rizzi(6), Paolo Kunderfranco(5), Paolo Gallo(4), Yusu Gu(4), Nancy D. Dalton(4), C Peschle(4), Riccardo Contu(4), Roberta Roncarati(4), Marcello Ceci(4), Carolina M. Greco(4), Claudia Bearzi(4), Désirée Bonci(3), Leonardo Elia(3), Kirk L. Peterson(3), Giacomo Frati(3)